<DOC>
	<DOCNO>NCT00235131</DOCNO>
	<brief_summary>This study look performance Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System treatment TASC C &amp; D superficial femoral artery long lesion ( 22 cm ) comparison Bard® Luminexx™ 6F Vascular Stent determine primary patency rate 6 12 month post procedure .</brief_summary>
	<brief_title>The Study Compare Cordis SMART™ Stent System With Bard® Luminexx™ Stent</brief_title>
	<detailed_description>This German multi-center prospective , randomize , two-arm study evaluate performance Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System compare C.R . Bard® Luminexx™ 6F Vascular Stent . Patients randomize 1:1 basis . It anticipate total 200 patient enter study . The study population consist approximately 200 symptomatic peripheral vascular disease patient TASC C &amp; D SFA lesion . The disease consist symptomatic , long de novo restenotic lesion ( &gt; 70 % stenosis ) occlusion ( 5 - 22 cm ) diagnostic imaging . The lesion must extend distal SFA popliteal artery . At least one distal popliteal artery must patent well one calf vessel . Reference vessel diameter must &gt; = 4.0 &lt; = 6.0 mm . Trial participant randomize Cordis S.M.A.R.T.™ CONTROL™ Nitinol Stent System Bard® Luminexx™ 6F Vascular Stent . Patients follow twelve month post-procedure . Study examinations do screening , procedure time , discharge , six , twelve month post procedure . This study conduct 15 investigational site Germany .</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Symptomatic leg ischemia Rutherford classification ( category 2 , 3 , 4 5 ) ; duration intermittent claudication ( category 23 ) least 3 month . One superficial femoral artery de novo restenotic lesion ( 70 % stenosis occlusion ) , lesion length 5 less 22 cm . Patent popliteal artery index side , i.e. , single vessel runoff well least one three vessel patent low 1/3 calf prior day procedure . Revascularisation involve limb within 30 day prior index procedure plan revascularisation within 30 day index procedure . Patients total occlusion iliac artery side must exclude . Previously implant stent ( ) treat artery site . Requiring stent placement distal superficial femoral artery popliteal artery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Peripheral Artery Occlusive Disease</keyword>
</DOC>